EP3285754A4 - Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière - Google Patents

Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière Download PDF

Info

Publication number
EP3285754A4
EP3285754A4 EP15890063.9A EP15890063A EP3285754A4 EP 3285754 A4 EP3285754 A4 EP 3285754A4 EP 15890063 A EP15890063 A EP 15890063A EP 3285754 A4 EP3285754 A4 EP 3285754A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
uric acid
formulations containing
blood levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15890063.9A
Other languages
German (de)
English (en)
Other versions
EP3285754A1 (fr
Inventor
Carl Oscar BROWN III
Hanpin Lim
Wei-Shu Lu
Tien-Kuen Chung
Chi-Kuang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TWi Biotechnology Inc
Original Assignee
TWi Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TWi Biotechnology Inc filed Critical TWi Biotechnology Inc
Publication of EP3285754A1 publication Critical patent/EP3285754A1/fr
Publication of EP3285754A4 publication Critical patent/EP3285754A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP15890063.9A 2015-04-20 2015-04-20 Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière Withdrawn EP3285754A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/026678 WO2016171656A1 (fr) 2015-04-20 2015-04-20 Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière

Publications (2)

Publication Number Publication Date
EP3285754A1 EP3285754A1 (fr) 2018-02-28
EP3285754A4 true EP3285754A4 (fr) 2018-12-19

Family

ID=57143313

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15890063.9A Withdrawn EP3285754A4 (fr) 2015-04-20 2015-04-20 Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière

Country Status (12)

Country Link
EP (1) EP3285754A4 (fr)
JP (1) JP2018513203A (fr)
KR (1) KR20180013880A (fr)
CN (1) CN107708681A (fr)
AU (1) AU2015392441A1 (fr)
BR (1) BR112017022509A2 (fr)
CA (1) CA2983394A1 (fr)
CO (1) CO2017011722A2 (fr)
IL (1) IL255073A0 (fr)
MX (1) MX2017013489A (fr)
RU (1) RU2690372C2 (fr)
WO (1) WO2016171656A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008146178A2 (fr) * 2007-05-30 2008-12-04 Wockhardt Research Centre Nouvelle forme posologique de comprimé
WO2009040702A2 (fr) * 2007-09-27 2009-04-02 Wockhardt Research Centre Compositions pharmaceutiques de rhéine ou de diacéréine
WO2009048940A2 (fr) * 2007-10-08 2009-04-16 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques de diacéréine
EP2349289A1 (fr) * 2008-10-28 2011-08-03 TWI Biotechnology, Inc. Compositions pharmaceutiques contenant de la diacéréine
US20110311594A1 (en) * 2010-06-22 2011-12-22 Shou-Chiung Chen Controlled release compositions with reduced food effect
US20120232044A1 (en) * 2011-03-11 2012-09-13 Twi Biotechnology, Inc. Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤
EP1795207A1 (fr) * 2004-10-01 2007-06-13 Nippon Zoki Pharmaceutical Co. Ltd. Préparation pharmaceutique solide
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
KR101190708B1 (ko) * 2010-03-12 2012-10-12 주식회사 대웅제약 모사프리드 또는 이의 염을 포함하는 서방형 약학 조성물
JP5865904B2 (ja) * 2010-06-16 2016-02-17 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド キサンチンオキシドレダクターゼ阻害剤またはキサンチンオキシダーゼ阻害剤の新規の調節放出剤形

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008146178A2 (fr) * 2007-05-30 2008-12-04 Wockhardt Research Centre Nouvelle forme posologique de comprimé
WO2009040702A2 (fr) * 2007-09-27 2009-04-02 Wockhardt Research Centre Compositions pharmaceutiques de rhéine ou de diacéréine
WO2009048940A2 (fr) * 2007-10-08 2009-04-16 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques de diacéréine
EP2349289A1 (fr) * 2008-10-28 2011-08-03 TWI Biotechnology, Inc. Compositions pharmaceutiques contenant de la diacéréine
US20110311594A1 (en) * 2010-06-22 2011-12-22 Shou-Chiung Chen Controlled release compositions with reduced food effect
US20120232044A1 (en) * 2011-03-11 2012-09-13 Twi Biotechnology, Inc. Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016171656A1 *

Also Published As

Publication number Publication date
CA2983394A1 (fr) 2016-10-27
EP3285754A1 (fr) 2018-02-28
CO2017011722A2 (es) 2018-04-19
MX2017013489A (es) 2018-05-22
JP2018513203A (ja) 2018-05-24
RU2017140079A (ru) 2019-05-20
BR112017022509A2 (pt) 2018-07-17
WO2016171656A1 (fr) 2016-10-27
RU2017140079A3 (fr) 2019-05-20
KR20180013880A (ko) 2018-02-07
RU2690372C2 (ru) 2019-06-03
CN107708681A (zh) 2018-02-16
IL255073A0 (en) 2017-12-31
AU2015392441A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
EP3568475A4 (fr) Solution de conservation d'acides nucléiques et ses procédés de fabrication et d'utilisation
EP3288958A4 (fr) Compositions d'acide obéticholique et procédés d'utilisation
EP3374494A4 (fr) Compositions crispr et leurs méthodes d'utilisation pour la thérapie génique
EP3416671A4 (fr) Vecteurs d'acide nucléique et leurs procédés thérapeutiques d'utilisation
EP3303634A4 (fr) Variants de cas9 et procédés d'utilisation associés
EP3645063A4 (fr) Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
EP3377070A4 (fr) Composés et leurs méthodes d'utilisation
EP3380181A4 (fr) Cathéter à gaine orientable et procédés d'utilisation associés
EP3297641A4 (fr) Procédés pour le stockage de sang total et compositions correspondantes
EP3600350A4 (fr) Échafaudage biologique comprenant des cellules thérapeutiques
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
EP3233091A4 (fr) Formulations d'acide hypochloreux et méthodes de traitement des maladies de peau
EP3710036A4 (fr) Compositions d'acide ascorbique stables et leurs procédés d'utilisation
EP3481819A4 (fr) Composés et utilisation de ces derniers pour réduire les niveaux d'acide urique
EP3416691A4 (fr) Supports d'acides nucléiques et leurs procédés thérapeutiques d'utilisation
EP3307172A4 (fr) Cathéters d'imagerie intravasculaire et procédés d'utilisation correspondants
EP3307381A4 (fr) Système d'électrodes multivecteur de patient et procédé d'utilisation
EP3093021A4 (fr) Composé d'acide pyridylaminoacétique et composition pharmaceutique contenant de l'huile de ricin polyoxyéthylénée
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
HK1232145A1 (zh) 雙功能化合物和用於降低尿酸水平的用途
EP3225234A4 (fr) Préparation contenant une forme cristalline d'acide chlorogénique et son utilisation
EP3139741A4 (fr) Procédés et compositions comprenant de l'acide 10-hydroxy-2-décénoïque
EP3325031A4 (fr) Échafaudages vasculaires à base de coulée et leurs procédés de fabrication
EP3445370A4 (fr) Procédés de préparation d'acide obéticholique et de dérivés de celui-ci

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20171114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20181120

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/192 20060101AFI20181114BHEP

Ipc: A61K 9/20 20060101ALI20181114BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20191024BHEP

Ipc: A61K 31/192 20060101AFI20191024BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20191203

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BROWN III, CARL OSCAR

Inventor name: CHEN, CHI-KUANG

Inventor name: LU, WEI-SHU

Inventor name: LIM, HANPIN

Inventor name: CHUNG, TIEN-KUEN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200603